Latest News

Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Receives Ghana Food and Drug Board Packaging and Insert Approvals for Paracetamol Tablets
December 06, 2012 08:30 ET

SUNYANI, GHANA--(Marketwire - Dec 6, 2012) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) has received approvals of its packaging and inserts for its lead OTC drug "Paracetamol" an over the counter analgesic drug. The Company has made submissions to the FDB labs for testing and awaits final approval from the national regulator before they can market and distribute the medicine within the country. The Company hopes to receive final approval before the end of 2012.

Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Approval From Food & Drugs Board Ghana for Anti-Malarial Pharmaceutical Gloderp® in Final Stages
November 28, 2012 08:30 ET

SUNYANI, GHANA--(Marketwire - Nov 28, 2012) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) strategic partner African Global Pharma Corp. (AGP) has informed us that the Food and Drugs Board of Ghana approval of the anti-malarial pharmaceutical Gloderp® is in the final stages of the registration process with the company anticipating full approval before this quarter end.

Emerging World Pharma Inc. Strategic Partner African Global Pharma GH in Negotiations to Finalize Agreement for Sale and Distribution of Current Pharmaceutical Line
November 15, 2012 08:30 ET

SUNYANI, GHANA--(Marketwire - Nov 15, 2012) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) is negotiating an agreement to distribute our full line of pharmaceutical products to several West African countries. Ghana acts as the gateway to a huge sub-regional market of over 250 million people.

Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Includes Production of Anti-Malarial Pharmaceutical Gloderp®
Nov 01, 2012

PRLog (Press Release) - Nov 01, 2012 - Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Includes Production of Anti-Malarial Pharmaceutical Gloderp®

Sunyani Ghana -- Emerging World Pharma Inc. (OTC:EWPI)-Emerging World Pharma Inc. strategic partner African Global Pharma Corp.(AGP) has initiated the production of the anti-malarial pharmaceutical called Gloderp®. It will be produced in capsule form in the (AGP) Ghana pharmaceutical manufacturing facility.

Gloderp® is used for the treatment of uncomplicated malaria caused by falciparum, vivax and or malariae. Each capsule will contain Dihydroartemisinin 40mg and Piperaquine Phosphate 320mg. African Global Pharma GH is currently the only producer of this type of anti-malarial medicine in capsule form in Ghana. AGP intends to maintain a sufficient inventory and availability of Gloderp® at its Sunyani Ghana production facility.

Emerging World Pharma Inc. President Provides Update From Global Pharma Corp. Annual Meeting
October 26, 2012 12:30 ET

SUNYANI, GHANA--(Marketwire - Oct 26, 2012) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma president Steve Ignatavicius was in attendance at the annual meeting of the board of directors from the company's strategic partner African Global Pharma Corp. The primary focus of the meeting was the restructuring and consolidation of operations at African Global Pharma Corp. GH.

Ghana Food and Drug Board (FDB) Grants African Global Pharma Inc. Regulatory Approval for Sale of Atenolol in Ghana
March 22, 2012 10:54 ET

MANASSAS VA--(Marketwire - Mar 22, 2012) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma's strategic partner, AFRICAN GLOBAL PHARMA is pleased to announce that the GHANA FDB has given approval for the registration of its "GLATEN TABLETS" ATENOLOL 50MG pursuant to section 18 of the Food and Drugs Act of 1992(PNDCL 305B).  

Emerging World Pharma Inc. Strategic Partner Global Pharma OU (GPE) Meets Packaging License Regulatory Requirements
October 25, 2011 09:00 ET

MANASSAS, VA--(Marketwire - Oct 25, 2011) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) company president, Brandon Keks confirmed that the company's European strategic partner in Estonia, Global Pharma Europe OÜ (GPE), has met all regulatory requirements in Estonia to receive its packaging license and GMP. The fulfillment of these requirements is a critical step for Global Pharma Europe moving forward to obtaining its full production license. Once approved, the company will initiate its marketing strategy into the European market.

Emerging World Pharma Inc. Updates on Sunyani, Ghana Manufacturing Facility
October 21, 2011 16:05 ET

MANASSAS, VA--(Marketwire - Oct 21, 2011) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Strategic partner, African Global Pharma (AGP), has now completed all regulatory requirements for production at its Sunyani, Ghana facility. Samples and dossiers of the AGP product line are currently awaiting final approval from the Food and Drug Board of Ghana.

Click here for more news!!!

 

Emerging World Pharma Inc. President Provides Update on Sunyani, Ghana Generic Drug Manufacturing Facility
Nov 12, 2010 12:00 ET

MANASSAS, VA--(Marketwire - November 12, 2010) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- company president Brandon Keks, currently on location in Sunyani, Ghana reports that the company's strategic partner African Global Pharma (AGP) will begin the trial production test runs at its manufacturing facility next week.

Emerging World Pharma Inc. Strategic Partner, African Global Pharma, Completes Construction and Set Up of the Sunyani, Ghana Factory
Oct 05, 2010 09:59 ET

MANASSAS, VA--(Marketwire - October 5, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI) strategic partner, African Global Pharma (AGP), has completed construction and set up of its generic drug manufacturing facility in Sunyani, Ghana.

Emerging World Pharma Inc. Strategic Partner African Global Pharma to Manufacture Generic Pharmaceuticals for the Catholic Diocese of Sunyani, Ghana
Jun 02, 2010 16:00 ET

MANASSAS, VA--(Marketwire - June 2, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI), strategic partner African Global Pharma (AGP), as part of an exclusive marketing and distribution agreement, will begin testing and manufacturing of generic pharmaceuticals for the Catholic Diocese of Sunyani, Ghana.

African Global Pharma Delays Ghana Manufacturing Facility Test Runs to Complete World Health Organization (WHO) Standards
May 17, 2010 11:12 ET

MANASSAS, VA--(Marketwire - May 17, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- After discussions with the Food and Drug Board Ghana (FDB), test runs expected to start in May have been pushed back 45 days.

Emerging World Pharma Inc. Management Approves Investment Allocation Into European Global Pharma
Apr 19, 2010 16:00 ET

MANASSAS, VA--(Marketwire - April 19, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI) president, Brandon Keks, confirmed today that the company has approved an ongoing investment allocation into European Global Pharma.

Emerging World Pharma Inc. Provides Update on African Global Pharma Generic Pharmaceutical Manufacturing Facility
Apr 12, 2010 16:00 ET

MANASSAS, VA--(Marketwire - April 12, 2010) - Emerging World Pharma Inc. (PINKSHEETS: EWPI) company president Brandon Keks reports that three shipping containers of production equipment and supplies are currently en route to port in Ghana.

Emerging World Pharma Inc. Continues Its Investment Into Generic Drug Manufacturing in Developing Countries
Apr 07, 2010 16:51 ET

MANASSAS, VA--(Marketwire - April 7, 2010) - Emerging World Pharma Inc. (PINKSHEETS: EWPI), has provided an initial investment into European Global Pharma that will be used to fund a generic drug manufacturing facility in Estonia. Estonia is a democratic parliamentary republic that is bordered by the Baltic Sea, Latvia, and Russia.

Emerging World Pharma Inc. Strategic Partner African Global Pharma Forms Exclusive Marketing and Distribution Agreement With the Catholic Diocese of Sunyani, Ghana
Apr 06, 2010 12:15 ET

MANASSAS, VA--(Marketwire - April 6, 2010) - Emerging World Pharma Inc. (PINKSHEETS: EWPI), an investor in generic based pharmaceutical companies manufacturing within developing nations,

Emerging World Pharma Inc. Presented Option to Invest in up to 25% of Profits in West African Generic Pharmaceutical Manufacturer
Mar 26, 2010 12:44 ET

MANASSAS, VA--(Marketwire - March 26, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI) has been granted an investment option to increase their percentage of profits by up to 25%. Emerging World Pharma had provided an initial investment to African Global Pharma,

Emerging World Pharma Inc. First Line of Production Equipment Commences in West African Generic Pharmaceutical Manufacturing Facility
March 22, 2010 16:28 ET

Company Plans to Exercise Profit Sharing Investment Option
MANASSAS, VA--(Marketwire - March 22, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- After recently returning from a tour of generic drug manufacturing facilities in West Africa, Emerging World Pharma president, Brandon Keks reports that the generic drug manufacturing firm the company has invested in

Emerging World Pharma Inc. Provides Initial Investment Into Private West African Generic Pharmaceutical Company
March 9th, 2010 12:14 ET

MANASSAS, VA--(Marketwire - March 9, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI), an investor in generic based pharmaceutical companies manufacturing within developing nations, has provided an initial investment into a private generic pharmaceutical company located in West Africa.

Emerging World Pharma Inc. Introduces Management Team
Feb 22, 2010 14:45 ET

MANASSES, VA--(Marketwire - February 22, 2010) - Emerging Growth Pharma Inc. (PINKSHEETS: EWPI), an investor in generic based pharmaceutical companies manufacturing within developing nations, is pleased to introduce the corporation's management line up.